FDA 483 - Rafaelito S. Victoria, MD - September 25, 2020

An FDA inspection of Rafaelito S. Victoria, MD in Anaheim, CA, revealed multiple deficiencies in the conduct of clinical investigations. The firm failed to report adverse events, adhere to the investigational plan, and maintain accurate case histories. Additionally, issues were noted with financial disclosure and informed consent procedures, indicating significant non-compliance with regulatory requirements for clinical trials.